Viracta Therapeutics
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients. Learn more
Launch date
Employees
Market cap
€8.7m
Enterprise valuation
€3m (Public information from Sep 2024)
Share price
$0.22 VIRX
Encinitas California (HQ)
Authorizing premium user...